McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK".
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| MCK | MCKESSON CORP | 2026-02-18 01:52:35 | 947.8 | 1.33 | 0.14 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MCK | 0000927653 | MCKESSON CORP | US58155Q1031 | 549300WZWOM80UCFSF54 | 943207296 | NYSE | 5122 | Wholesale-Drugs, Proprietaries & Druggists' Sundries | 0331 | DE | 6555 STATE HIGHWAY 161 | IRVING | TX | 75039 | UNITED STATES | US | 972-446-4800 | 6555 STATE HIGHWAY 161, IRVING, TX, 75039 | 6555 STATE HIGHWAY 161, IRVING, TX, 75039 | MCKESSON HBOC INC | Healthcare | 1833 | Brian S. Tyler | 45,000 | http://mckesson.com | 62,700,000,000 | 280,000,000 | 122,487,456 | McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK". | 2026-02-12 15:13:26 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 62,700,000,000 | 4,900,000,000 | 8.4775 | 125,112,236 | -4,873,278 | -3.7491 |
| 2024 | 57,800,000,000 | 9,600,000,000 | 19.917 | 129,985,514 | -5,616,748 | -4.1421 |
| 2023 | 48,200,000,000 | 17,800,000,000 | 58.5526 | 135,602,262 | -9,763,062 | -6.7162 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Michele Lau | Chief Legal Officer, Executive Vice President | 2025 | 720,417 | 0 | 3,001,093 | 857,296 | 647,899 | 5,226,705 |
| Leann B. Smith | Executive Vice President | 2025 | 658,750 | 0 | 2,200,981 | 783,913 | 74,255 | 3,717,899 |
| Brian S. Tyler | Chief Executive Officer | 2025 | 1,541,667 | 0 | 14,500,512 | 3,669,167 | 450,368 | 20,161,714 |
| Britt J. Vitaloneexecutive Vice | President | 2025 | 1,025,000 | 0 | 5,000,853 | 1,524,688 | 131,640 | 7,682,181 |
| Thomas L. Rodgers | Executive Vice President | 2025 | 631,117 | 0 | 1,751,295 | 751,029 | 79,866 | 3,213,307 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 45,000 |
| 2024 | 51,000 |
| 2023 | 51,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 359,051,000,000 | 308,951,000,000 | 276,711,000,000 |
| Cost Of Revenue | 345,728,000,000 | 296,123,000,000 | 264,353,000,000 |
| Gross Profit | 13,323,000,000 | 12,828,000,000 | 12,358,000,000 |
| Research And Development Expenses | — | — | — |
| General And Administrative Expenses | 8,507,000,000 | 8,657,000,000 | 7,776,000,000 |
| Operating Expenses | 8,901,000,000 | 8,919,000,000 | 7,977,000,000 |
| Operating Income | 4,422,000,000 | 3,909,000,000 | 4,381,000,000 |
| Net Income | 3,295,000,000 | 3,002,000,000 | 3,560,000,000 |
| Earnings Per Share Basic | 25.86 | 22.54 | 25.23 |
| Earnings Per Share Diluted | 25.72 | 22.39 | 25.03 |
| Weighted Average Shares Outstanding Basic | 127,400,000 | 133,200,000 | 141,100,000 |
| Weighted Average Shares Outstanding Diluted | 128,100,000 | 134,100,000 | 142,200,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 5,691,000,000 | 4,583,000,000 | 4,678,000,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 25,643,000,000 | 21,622,000,000 | 19,410,000,000 |
| Inventories | 23,001,000,000 | 21,139,000,000 | 19,691,000,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | — | — | — |
| Total Assets Current | 55,398,000,000 | 47,970,000,000 | 44,292,000,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 2,502,000,000 | 2,316,000,000 | 2,177,000,000 |
| Other Assets Non Current | 3,972,000,000 | 3,186,000,000 | 1,992,000,000 |
| Total Assets Non Current | 19,742,000,000 | 19,473,000,000 | 18,028,000,000 |
| Total Assets | 75,140,000,000 | 67,443,000,000 | 62,320,000,000 |
| Accounts Payable | 55,330,000,000 | 47,097,000,000 | 42,490,000,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 1,191,000,000 | 50,000,000 | 968,000,000 |
| Other Liabilities Current | 4,825,000,000 | 4,915,000,000 | 4,195,000,000 |
| Total Liabilities Current | 61,604,000,000 | 52,357,000,000 | 47,957,000,000 |
| Long Term Debt | 5,654,000,000 | 5,629,000,000 | 5,594,000,000 |
| Other Liabilities Non Current | 2,659,000,000 | 2,610,000,000 | 1,813,000,000 |
| Total Liabilities Non Current | -61,557,000,000 | -52,316,000,000 | -47,904,000,000 |
| Total Liabilities | 47,000,000 | 41,000,000 | 53,000,000 |
| Common Stock | 3,000,000 | 3,000,000 | 3,000,000 |
| Retained Earnings | 17,921,000,000 | 14,978,000,000 | 12,295,000,000 |
| Accumulated Other Comprehensive Income | -932,000,000 | -881,000,000 | -905,000,000 |
| Total Shareholders Equity | -2,074,000,000 | -1,971,000,000 | -1,857,000,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 394,000,000 | 382,000,000 | 360,000,000 |
| Share Based Compensation Expense | 141,000,000 | 110,000,000 | 75,000,000 |
| Other Non Cash Income Expense | -424,000,000 | -233,000,000 | -298,000,000 |
| Change In Accounts Receivable | 3,935,000,000 | 2,954,000,000 | 1,082,000,000 |
| Change In Inventories | 2,270,000,000 | 1,294,000,000 | 1,259,000,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | 8,301,000,000 | 4,587,000,000 | 3,788,000,000 |
| Change In Other Liabilities | 281,000,000 | -37,000,000 | -56,000,000 |
| Cash From Operating Activities | 6,085,000,000 | 4,314,000,000 | 5,159,000,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 859,000,000 | 687,000,000 | 558,000,000 |
| Acquisition Of Business | 24,000,000 | 272,000,000 | 867,000,000 |
| Other Investing Activities | 29,000,000 | 160,000,000 | 194,000,000 |
| Cash From Investing Activities | -733,000,000 | -1,072,000,000 | -542,000,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | 352,000,000 | 320,000,000 | 296,000,000 |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | 3,172,000,000 | 3,023,000,000 | 3,665,000,000 |
| Issuance Of Long Term Debt | 498,000,000 | 991,000,000 | 997,000,000 |
| Repayment Of Long Term Debt | 519,000,000 | 288,000,000 | 1,274,000,000 |
| Other Financing Activities | -554,000,000 | -175,000,000 | -324,000,000 |
| Cash From Financing Activities | -3,965,000,000 | -3,342,000,000 | -4,368,000,000 |
| Change In Cash | 1,371,000,000 | -94,000,000 | 744,000,000 |
| Cash At End Of Period | 5,691,000,000 | 4,583,000,000 | 4,678,000,000 |
| Income Taxes Paid | 1,124,000,000 | 901,000,000 | 562,000,000 |
| Interest Paid | 273,000,000 | 234,000,000 | 224,000,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | 25.86 | 22.54 | 25.23 |
| Price To Earnings Ratio | 26.0244 | 23.8017 | 14.1122 |
| Earnings Growth Rate | 14.7294 | -10.6619 | 244.6721 |
| Price Earnings To Growth Ratio | 1.7668 | -2.2324 | 0.0577 |
| Book Value Per Share | 589.427 | 506.021 | 441.297 |
| Price To Book Ratio | 1.1418 | 1.0602 | 0.8068 |
| Ebitda | 5,078,000,000 | 4,537,000,000 | 4,730,000,000 |
| Enterprise Value | 86,892,926,000 | 72,556,468,000 | 52,122,655,000 |
| Dividend Yield | 0.0041 | 0.0045 | 0.0059 |
| Dividend Payout Ratio | 0.1068 | 0.1066 | 0.0831 |
| Debt To Equity Ratio | -3.3004 | -2.8813 | -3.5337 |
| Capital Expenditures | 580,000,000 | 521,000,000 | 445,000,000 |
| Free Cash Flow | 5,505,000,000 | 3,793,000,000 | 4,714,000,000 |
| Return On Equity | -1.5887 | -1.5231 | -1.9171 |
| One Year Beta | 0.0586 | -0.0181 | 0.3911 |
| Three Year Beta | 0.2577 | 0.3683 | 0.6097 |
| Five Year Beta | 0.4919 | 0.7207 | 0.7721 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Lau Michele | EVP and Chief Legal Officer | 2026-02-11 | 303 | D | 5,972 |
| Smith LeAnn B | EVP & Chief HR Officer | 2026-02-10 | 508 | A | 3,308 |
| Smith LeAnn B | EVP & Chief HR Officer | 2026-02-10 | 129 | D | 3,179 |
| Smith LeAnn B | EVP & Chief HR Officer | 2026-02-10 | 508 | D | 0 |
| Lau Michele | EVP and Chief Legal Officer | 2026-02-09 | 3,990 | A | 7,237 |
| Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Markwayne Mullin | Senator | 2026-02-04 | Purchase | 2026-01-05 | Spouse | $15,001 - $50,000 |
| Markwayne Mullin | Senator | 2026-02-04 | Purchase | 2026-01-05 | Self | $15,001 - $50,000 |
| Sheldon Whitehouse | Senator | 2017-10-12 | Sale (Full) | 2017-09-20 | Joint | $15,001 - $50,000 |
| Sheldon Whitehouse | Senator | 2017-03-15 | Purchase | 2017-02-23 | Joint | $1,001 - $15,000 |
| Sheldon Whitehouse | Senator | 2016-12-12 | Purchase | 2016-11-15 | Joint | $1,001 - $15,000 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Jared Moskowitz | 2026-01-16 | FL23 | Purchase | 2025-12-02 | Child | $1,001 - $15,000 |
| Jared Moskowitz | 2026-01-16 | FL23 | Purchase | 2025-12-02 | — | $1,001 - $15,000 |
| Julia Letlow | 2026-01-13 | LA05 | Purchase | 2024-12-18 | — | $1,001 - $15,000 |
| Gilbert Cisneros | 2026-01-12 | CA31 | Sale | 2025-12-19 | — | $1,001 - $15,000 |
| Gilbert Cisneros | 2025-12-15 | CA31 | Purchase | 2025-11-18 | — | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Hilltop Holdings Inc. | 2025-12-31 | 1,650,918 | 2,013 | 820.1282 |
| Investment Management Corp of Ontario | 2025-12-31 | 15,420,632 | 18,799 | 820.29 |
| Zurich Insurance Group Ltd/FI | 2025-12-31 | 25,009,002 | 30,488 | 820.29 |
| PharVision Advisers, LLC | 2025-12-31 | 213,275 | 260 | 820.2885 |
| TUDOR INVESTMENT CORP ET AL | 2025-12-31 | 410,145 | 500 | 820.29 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| EMPOWER FUNDS, INC. | 2025-12-31 | Institutional Class | MXKWX | 18,817 | 15,435,396.75 | 0.167 |
| EMPOWER FUNDS, INC. | 2025-12-31 | Investor Class | MXVIX | 18,817 | 15,435,396.75 | 0.167 |
| EMPOWER FUNDS, INC. | 2025-12-31 | Institutional Class | MXCOX | 800,000 | 822,200.63 | 0.0172 |
| EMPOWER FUNDS, INC. | 2025-12-31 | Investor Class | MXBIX | 800,000 | 822,200.63 | 0.0172 |
| EMPOWER FUNDS, INC. | 2025-12-31 | Institutional Class | MXGSX | 7,164 | 5,876,557.59 | 0.2959 |